Clinical Trial Update: The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether fexofenadine hydrochloride can affect prognosis after acute myocardial infarction and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Fexofenadine hydrochloride (fexofenadine hydrochloride)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Zhejiang University | Phase 3 | Status: RECRUITING